CHRONIC INFLAMMATORY DISEASES. “Phase I/Phase II clinical trials have been concluded or are still underway by Astra-Zeneca, Pfizer, Evotec, and GlaxoSmithKline to test safety and efficacy of drug-like P2X7R blockers in several chronic inflammatory diseases such as osteoarthritis, rheumatoid arthritis, chronic obstructive pulmonary disease, and CD.”
https://lnkd.in/eNNPn5D
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022